Get Premium to unlock powerful stock data
FRA:038 ()  
NovoCure Ltd logo

NovoCure Ltd

€ 69.30 (+0.29%) Jul 5
P/E:
At Loss
P/B:
18.05
Market Cap:
€ 7.47B ($ 7.64B)
Enterprise V:
€ 7.13B ($ 7.29B)
Volume:
-
Avg Vol (2M):
58.00
Also Trade In:
Volume:
-
Market Cap €:
7.47B
Market Cap $:
7.64B
PE Ratio:
At Loss
Avg Vol (2-Month):
58.00
Enterprise Value €:
7.13B
Enterprise Value $:
7.29B
PB Ratio:
18.05
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

NovoCure Ltd
NAICS : 339112 SIC : 3845
Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF
Description
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.61
Equity-to-Asset 0.38
Debt-to-Equity 1.33
Debt-to-EBITDA -16.72
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.1
Distress
Grey
Safe
Beneish M-Score -2.88
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.4
9-Day RSI 58.63
14-Day RSI 54.27
6-1 Month Momentum % 12.19
12-1 Month Momentum % -52.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.46
Quick Ratio 8.23
Cash Ratio 7.3
Days Inventory 82.17
Days Sales Outstanding 64.01
Days Payable 195.52

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.7

Financials (Next Earnings Date:2022-07-28)

FRA:038's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 467.17
EPS (TTM) (€) -0.484
Beta 0.21
Volatility % 48.52
14-Day RSI 54.27
14-Day ATR (€) 2.791622
20-Day SMA (€) 64.9785
12-1 Month Momentum % -52.02
52-Week Range (€) 53.39 - 162.2
Shares Outstanding (Mil) 104.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NovoCure Ltd Filings

Document Form Filing Date
No Filing Data